W. Grant McGimpsey, PhD
Christopher R. Lambert, PhD
Medical Devices/Medical Diagnostics
TSC MEMBER INSTITUTION(S):
Worcester Polytechnic Institute
Department of Defense
ACTIVE SURFACE TECHNOLOGIES, INC.
ABOUT THE COMPANY:
Imagine a handheld device that lets clinicians detect early signs of renal failure while there is still time to save a patient’s kidneys. Now imagine that the same device can quickly give doctors the information they need to make the best possible decisions about diagnostic tests and treatment. The founders of Active Surface Technologies, Inc. (ASTI) have done more than imagine such technology; they’ve developed a working prototype and are seeking to bring it to market.
The company is developing a battery-operated handheld device that takes highly accurate measurements of renal disease biomarkers such as potassium, urea, and creatinine and executes two measurement techniques simultaneously in a reusable sensor module. The combination of dual detection and reusable format allows continuous self-calibration, giving the ASTI instrument a significant advantage over single-use instruments currently in the marketplace. In other work, ASTI is developing other thin film technology for medical, sensor, and energy applications.
UNIVERSITY-BASED RESEARCH CONNECTION:
Grant McGimpsey is a faculty member in Worcester Polytechnic Institute’s Chemistry and Biochemistry Department and director of WPI’s Bioengineering Institute (BEI). Christopher Lambert is an associate research professor in BEI. The technology developed by Active Surface Technologies is the product of many years of research on surface chemistry, thin film devices, nanotechnology, molecular scale devices, micro- and nano-fluidics, and biosensors.
ROLE OF FEDERAL RESEARCH FUNDING:
The early R&D on the ASTI sensor device was supported by the Department of Defense through the US Army Medical Research and Materiel Command, which oversees the Army’s Telemedicine and Advanced Technologies Research Center (TATRC).
Read The Full Report Here